People · Operator
Named in public records as an officer, director or promoter · active 2009–2021 · Pharmaceuticals, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Vero Biotech Inc. | — | Pharmaceuticals | Series B | $82.1M | $525.0M | 2009 |
| Pager, Inc. | — | Other | Series B | $74.1M | $264.3M | 2020 |
| Broadlane Holdings LLC | — | Other | Series A | $5.9M | $15.1M | 2009 |
Steven Shulman at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Steven Shulman on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Todd Kimmel | 1 | 13 |
| Adam Goulburn | 1 | 10 |
| Eric Kim | 1 | 7 |
| Todd Brady | 1 | 7 |
| Philip Eytan | 1 | 5 |
| James O'Brien | 1 | 5 |
| Leslie V. Norwalk | 1 | 5 |
| Gaspard De Dreuzy | 1 | 4 |
| Darren Dworkin | 1 | 3 |
| Oscar Salazar | 1 | 3 |
| Ian Sacks | 1 | 3 |
| Travis Nelson | 1 | 3 |
| Glenn F. Miller | 1 | 2 |
| Lisa Skeete Tatum | 1 | 2 |
| Paul Scott Antinori | 1 | 2 |
| Arthur H. Spiegel | 1 | 2 |
| Patrick T. Ryan | 1 | 2 |
| Theo Melas-Kyriazi | 1 | 2 |
| Anthony Loumidis | 1 | 2 |
| Neal Moszkowski | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.